Dose and aging effect on patients reported treatment benefit switching from the first overactive bladder therapy with tolterodine ER to fesoterodine: post-hoc analysis from an observational and retrospective study

Peer Review reports

Original Submission
16 Feb 2012	Submitted	Original manuscript
27 Mar 2012	Reviewed	Reviewer Report - Christopher Chermansky
30 Mar 2012	Reviewed	Reviewer Report - alayne markland
4 May 2012	Author responded	Author comments - Isabel Lizarraga
Resubmission - Version 2
4 May 2012	Submitted	Manuscript version 2
5 Jun 2012	Reviewed	Reviewer Report - Christopher Chermansky
6 Jul 2012	Author responded	Author comments - Isabel Lizarraga
Resubmission - Version 3
6 Jul 2012	Submitted	Manuscript version 3
Publishing
10 Jul 2012	Editorially accepted
26 Jul 2012	Article published	10.1186/1471-2490-12-19

Back to article page